Publicaciones en colaboración con investigadores/as de Massachusetts General Hospital (20)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  3. Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes

    Nature Communications, Vol. 15, Núm. 1

  4. Genome-Wide Gene-Environment Interaction Analyses to Understand the Relationship between Red Meat and Processed Meat Intake and Colorectal Cancer Risk

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 33, Núm. 3, pp. 400-410

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (Nature Genetics, (2023), 55, 1, (89-99), 10.1038/s41588-022-01222-9)

    Nature Genetics

  3. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

    Nature Genetics, Vol. 55, Núm. 1, pp. 89-99

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Response to Li and Hopper

    American Journal of Human Genetics

2020

  1. Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study

    BMC Medicine, Vol. 18, Núm. 1

  2. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses

    Gastroenterology, Vol. 158, Núm. 5, pp. 1300-1312.e20

  3. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses

    BMC medicine, Vol. 18, Núm. 1, pp. 229

  4. Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer

    Gastroenterology, Vol. 158, Núm. 5, pp. 1274-1286.e12

  5. Exploratory genome-wide interaction analysis of nonsteroidal anti-inflammatory drugs and predicted gene expression on colorectal cancer risk

    Cancer Epidemiology Biomarkers and Prevention, Vol. 29, Núm. 9, pp. 1800-1808

  6. Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk

    American Journal of Human Genetics, Vol. 107, Núm. 3, pp. 432-444

  7. Mendelian randomization of circulating polyunsaturated fatty acids and colorectal cancer risk

    Cancer Epidemiology Biomarkers and Prevention, Vol. 29, Núm. 4, pp. 860-870

2019

  1. Correction to: Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer (Human Genetics, (2019), 138, 4, (307-326), 10.1007/s00439-019-01989-8)

    Human Genetics

  2. Discovery of common and rare genetic risk variants for colorectal cancer

    Nature Genetics, Vol. 51, Núm. 1, pp. 76-87

  3. Mendelian randomization analysis of C-reactive protein on colorectal cancer risk

    International Journal of Epidemiology, Vol. 48, Núm. 3, pp. 767-780

  4. Novel common genetic susceptibility loci for colorectal cancer

    Journal of the National Cancer Institute, Vol. 111, Núm. 2, pp. 146-157